Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hypercoagulability in various autoimmune diseases: no association with factor V Leiden mutation.

Haematologia - 1 Jan 2000

Regéczy N, Balogh I, Lakos G, Zeher M, Bodolay E, Szücs G, Kiss E, Ajzner E, Szegedi G

Abstract excerpt

The coagulation factor V Leiden mutation, leading to resistance to activated protein C (APC), is the most common inherited risk factor for venous thrombosis. In various systemic autoimmune diseases the hypercoagulable state was shown to be associated with the presence of antiphospholipid antibodies (aPL). Our aim was to determine the prevalence of both, Leiden mutation and aPL in autoimmune diseases and their...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Activated Protein C Resistance
Share to Antibodies, Antiphospholipid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antiphospholipid Syndrome

Share to Connective Tissue Diseases

Share to Scleroderma, Systemic

Share to Sjogren's Syndrome

Share to Thromboembolism

Share to Thrombophilia

Source

Identifiers

PMID: 10841323
DOI: 10.1163/15685590051129869

Genes

APC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hypercoagulability in various autoimmune diseases: no association with factor V Leiden mutation.PMID 10841323Read ↗

Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.Semantic proximity Read ↗

Can inherited thrombophilia modulate the clinical phenotype of patients with antiphospholipid syndrome?Semantic proximity Read ↗

Novel antiphospholipid antibodies in autoimmune bullous diseases.Semantic proximity Read ↗

The prevalence and clinical significance of inherited thrombophilic risk factors in patients with antiphospholipid syndrome.Semantic proximity Read ↗

CLINICAL AND GENETIC PECULIARITIES OF VASCULAR MANIFESTATIONS OF ANTIPHOSPHOLIPID SYNDROME (CASE REPORT).Semantic proximity Read ↗

Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors.Semantic proximity Read ↗

Thrombosis risk in systemic lupus erythematosus: the role of thrombophilic risk factors.Semantic proximity Read ↗

Current debates in antiphospholipid syndrome: the acquired antibody-mediated thrombophilia.Semantic proximity Read ↗

Venous thromboembolic disease: risk factors and laboratory investigation.Semantic proximity Read ↗

Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosus.Semantic proximity Read ↗

Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis.Semantic proximity Read ↗

Anti-cofactor autoantibodies in systemic lupus erythematosus: prevalence, clinical and HLA class II associations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.